Literature DB >> 22296994

The effect of Clostridium perfringens type C strain CN3685 and its isogenic beta toxin null mutant in goats.

J P Garcia1, J Beingesser, D J Fisher, S Sayeed, B A McClane, H Posthaus, F A Uzal.   

Abstract

Clostridium perfringens type C is an important cause of enteritis and/or enterocolitis in several animal species, including pigs, sheep, goats, horses and humans. The disease is a classic enterotoxemia and the enteric lesions and associated systemic effects are thought to be caused primarily by beta toxin (CPB), one of two typing toxins produced by C. perfringens type C. This has been demonstrated recently by fulfilling molecular Koch's postulates in rabbits and mice. We present here an experimental study to fulfill these postulates in goats, a natural host of C. perfringens type C disease. Nine healthy male or female Anglo Nubian goat kids were inoculated with the virulent C. perfringens type C wild-type strain CN3685, an isogenic CPB null mutant or a strain where the cpb null mutation had been reversed. Three goats inoculated with the wild-type strain presented abdominal pain, hemorrhagic diarrhea, necrotizing enterocolitis, pulmonary edema, hydropericardium and death within 24h of inoculation. Two goats inoculated with the CPB null mutant and two goats inoculated with sterile culture media (negative controls) remained clinically healthy during 24h after inoculation and no gross or histological abnormalities were observed in the tissues of any of them. Reversal of the null mutation to partially restore CPB production also increased virulence; 2 goats inoculated with this reversed mutant presented clinical and pathological changes similar to those observed in goats inoculated with the wild-type strain, except that spontaneous death was not observed. These results indicate that CPB is required for C. perfringens type C to induce disease in goats, supporting a key role for this toxin in natural C. perfringens type C disease pathogenesis.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22296994      PMCID: PMC3348370          DOI: 10.1016/j.vetmic.2012.01.005

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  15 in total

1.  Some properties of beta-toxin produced by Clostridium perfringens type C.

Authors:  J Sakurai; C L Duncan
Journal:  Infect Immun       Date:  1978-08       Impact factor: 3.441

2.  Dissecting the contributions of Clostridium perfringens type C toxins to lethality in the mouse intravenous injection model.

Authors:  Derek J Fisher; Mariano E Fernandez-Miyakawa; Sameera Sayeed; Rachael Poon; Victoria Adams; Julian I Rood; Francisco A Uzal; Bruce A McClane
Journal:  Infect Immun       Date:  2006-09       Impact factor: 3.441

3.  Clostridium perfringens beta-toxin targets endothelial cells in necrotizing enteritis in piglets.

Authors:  J Miclard; M Jäggi; E Sutter; M Wyder; B Grabscheid; H Posthaus
Journal:  Vet Microbiol       Date:  2009-01-22       Impact factor: 3.293

4.  Experimental pigbel: the production and pathology of necrotizing enteritis due to Clostridium welchii type C in the guinea-pig.

Authors:  G Lawrence; R Cooke
Journal:  Br J Exp Pathol       Date:  1980-06

5.  Prevalence of cpb2, encoding beta2 toxin, in Clostridium perfringens field isolates: correlation of genotype with phenotype.

Authors:  Dawn M Bueschel; B Helen Jost; Stephen J Billington; Hien T Trinh; J Glenn Songer
Journal:  Vet Microbiol       Date:  2003-07-01       Impact factor: 3.293

6.  Effects of Clostridium perfringens beta-toxin on the rabbit small intestine and colon.

Authors:  Jorge E Vidal; Bruce A McClane; Juliann Saputo; Jaquelyn Parker; Francisco A Uzal
Journal:  Infect Immun       Date:  2008-07-14       Impact factor: 3.441

7.  Beta toxin is essential for the intestinal virulence of Clostridium perfringens type C disease isolate CN3685 in a rabbit ileal loop model.

Authors:  Sameera Sayeed; Francisco A Uzal; Derek J Fisher; Juliann Saputo; Jorge E Vidal; Yue Chen; Phalguni Gupta; Julian I Rood; Bruce A McClane
Journal:  Mol Microbiol       Date:  2008-01       Impact factor: 3.501

8.  Enteritis necroticans 'pigbel' in a Japanese diabetic adult.

Authors:  Tomomichi Matsuda; Yuji Okada; Eiji Inagi; Yasushi Tanabe; Yozo Shimizu; Kazuo Nagashima; Jun Sakurai; Masahiro Nagahama; Shinya Tanaka
Journal:  Pathol Int       Date:  2007-09       Impact factor: 2.534

Review 9.  Clostridial enteric infections in pigs.

Authors:  J Glenn Songer; Francisco A Uzal
Journal:  J Vet Diagn Invest       Date:  2005-11       Impact factor: 1.279

10.  Development and application of new mouse models to study the pathogenesis of Clostridium perfringens type C Enterotoxemias.

Authors:  Francisco A Uzal; Juliann Saputo; Sameera Sayeed; Jorge E Vidal; Derek J Fisher; Rachael Poon; Vicki Adams; Mariano E Fernandez-Miyakawa; Julian I Rood; Bruce A McClane
Journal:  Infect Immun       Date:  2009-10-05       Impact factor: 3.441

View more
  16 in total

Review 1.  Comparative pathogenesis of enteric clostridial infections in humans and animals.

Authors:  Francisco A Uzal; Mauricio A Navarro; Jihong Li; John C Freedman; Archana Shrestha; Bruce A McClane
Journal:  Anaerobe       Date:  2018-06-05       Impact factor: 3.331

Review 2.  Towards an understanding of the role of Clostridium perfringens toxins in human and animal disease.

Authors:  Francisco A Uzal; John C Freedman; Archana Shrestha; James R Theoret; Jorge Garcia; Milena M Awad; Vicki Adams; Robert J Moore; Julian I Rood; Bruce A McClane
Journal:  Future Microbiol       Date:  2014       Impact factor: 3.165

3.  Prevention and treatment of Clostridium perfringens epsilon toxin intoxication in mice with a neutralizing monoclonal antibody (c4D7) produced in Nicotiana benthamiana.

Authors:  J P Garcia; J Beingesser; O Bohorov; N Bohorova; C Goodman; D Kim; M Pauly; J Velasco; K Whaley; L Zeitlin; C J Roy; F A Uzal
Journal:  Toxicon       Date:  2014-06-17       Impact factor: 3.033

4.  Native or Proteolytically Activated NanI Sialidase Enhances the Binding and Cytotoxic Activity of Clostridium perfringens Enterotoxin and Beta Toxin.

Authors:  James R Theoret; Jihong Li; Mauricio A Navarro; Jorge P Garcia; Francisco A Uzal; Bruce A McClane
Journal:  Infect Immun       Date:  2017-12-19       Impact factor: 3.441

Review 5.  Animal models to study the pathogenesis of human and animal Clostridium perfringens infections.

Authors:  Francisco A Uzal; Bruce A McClane; Jackie K Cheung; James Theoret; Jorge P Garcia; Robert J Moore; Julian I Rood
Journal:  Vet Microbiol       Date:  2015-02-25       Impact factor: 3.293

6.  Synergistic effects of Clostridium perfringens enterotoxin and beta toxin in rabbit small intestinal loops.

Authors:  Menglin Ma; Abhijit Gurjar; James R Theoret; Jorge P Garcia; Juliann Beingesser; John C Freedman; Derek J Fisher; Bruce A McClane; Francisco A Uzal
Journal:  Infect Immun       Date:  2014-04-28       Impact factor: 3.441

Review 7.  Host cell-induced signaling causes Clostridium perfringens to upregulate production of toxins important for intestinal infections.

Authors:  Jianming Chen; Menglin Ma; Francisco A Uzal; Bruce A McClane
Journal:  Gut Microbes       Date:  2013-09-10

Review 8.  Toxin plasmids of Clostridium perfringens.

Authors:  Jihong Li; Vicki Adams; Trudi L Bannam; Kazuaki Miyamoto; Jorge P Garcia; Francisco A Uzal; Julian I Rood; Bruce A McClane
Journal:  Microbiol Mol Biol Rev       Date:  2013-06       Impact factor: 11.056

Review 9.  Expansion of the Clostridium perfringens toxin-based typing scheme.

Authors:  Julian I Rood; Vicki Adams; Jake Lacey; Dena Lyras; Bruce A McClane; Stephen B Melville; Robert J Moore; Michel R Popoff; Mahfuzur R Sarker; J Glenn Songer; Francisco A Uzal; Filip Van Immerseel
Journal:  Anaerobe       Date:  2018-04-20       Impact factor: 3.331

10.  Identifying the Basis for VirS/VirR Two-Component Regulatory System Control of Clostridium perfringens Beta-Toxin Production.

Authors:  Iman Mehdizadeh Gohari; Jihong Li; Bruce A McClane
Journal:  J Bacteriol       Date:  2021-08-20       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.